Current approved drugs for aquatic species

摘要

Aquaculture is an important developing international industry. Approved pharmaceutical agents available to veterinarians in the United States are limited in their therapeutic scope and efficacy. Ensuring preharvest food safety and preventing illegaldrug residues are extremely important issues in the selection of therapeutic regimens for aquatic species. Currently available therapeutic substances used in aquaculture can be classilied as FDA-approved drugs, FDA-unapproved low-regulatory-priority treatments (LRPTs), Environmental Protection Agency (EPA)-registered products (eg, algaecides, herbicides, and fish toxicants), USDA-licensed biologies (eg, bacterins and diagnostics), and feeds (eg, glycans and pro-biotics). As for other food-producing species, extralabel use of drugs in feed formulations is illegal. However, a recent compliance policy guideline outlines criteria by which veterinarians may use extralabel treatments in the feed of minor species on a limited basis. This Food Animal ResidueAvoidance Databank Digest reviews drugs currently approved for use in aquatic species (Appendix 1), chemicals that are not approved but are considered by the PDAs Center for Veterinary Medicine (CVM) to be of low regulatory priority (Appendix 2), and policies that can affect the use of these products.